Abstract
Background: Recently, increasing antibiotic resistance is causing serious publichealth concerns worldwide. This phenomenon increased patient's morbidity and mortality rate, particularly in immunocompromised individuals.
Methods: Considering that antimicrobial resistance can vary according to geographical location, we investigated the status of antibiotic resistance in Ilam province from 2008 to 2013.
Results: The results of our study showed that antibiotic resistance rates to aztreonam, cefotaxime, ceftazidime and ceftriaxone were 38%, 39%, 43% and 48% respectively.
Conclusion: Antibiotic resistance had increased (except for aztreonam) during the period from 2008 to 2013.
Keywords: Antibiotic resistances, antimicrobial resistance, meta-analysis, monobactam, Ilam, ceftazidime.
Recent Patents on Anti-Infective Drug Discovery
Title:3rd Generation of Cephalosporins and Monobactam Resistant Among Pathogenic Bacteria Collected from Ilam Hospitals During 2008 to 2015: A Systematic Review and Meta-Analysis
Volume: 12 Issue: 1
Author(s): Saeed Hemati, Sobhan Ghafourian, Nourkhoda Sadeghfard, Zahra Mahdavi, Abbas Maleki, Fatemeh Sayehmiri, Kouroush Sayehmiri, Lidija Bogdanovic and Morovat Taherikalani*
Affiliation:
- Razi Herbal Medicines Research Center & Department of Microbiology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad,Iran
Keywords: Antibiotic resistances, antimicrobial resistance, meta-analysis, monobactam, Ilam, ceftazidime.
Abstract: Background: Recently, increasing antibiotic resistance is causing serious publichealth concerns worldwide. This phenomenon increased patient's morbidity and mortality rate, particularly in immunocompromised individuals.
Methods: Considering that antimicrobial resistance can vary according to geographical location, we investigated the status of antibiotic resistance in Ilam province from 2008 to 2013.
Results: The results of our study showed that antibiotic resistance rates to aztreonam, cefotaxime, ceftazidime and ceftriaxone were 38%, 39%, 43% and 48% respectively.
Conclusion: Antibiotic resistance had increased (except for aztreonam) during the period from 2008 to 2013.
Export Options
About this article
Cite this article as:
Hemati Saeed, Ghafourian Sobhan, Sadeghfard Nourkhoda, Mahdavi Zahra, Maleki Abbas, Sayehmiri Fatemeh, Sayehmiri Kouroush, Bogdanovic Lidija and Taherikalani Morovat*, 3rd Generation of Cephalosporins and Monobactam Resistant Among Pathogenic Bacteria Collected from Ilam Hospitals During 2008 to 2015: A Systematic Review and Meta-Analysis, Recent Patents on Anti-Infective Drug Discovery 2017; 12(1) . https://dx.doi.org/10.2174/1574891X12666170130101006
DOI https://dx.doi.org/10.2174/1574891X12666170130101006 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Severe Community-Acquired Pneumonia (CAP) due to Atypical Pathogens
Current Respiratory Medicine Reviews Brucella Carbonic Anhydrases: New Targets for Designing Anti-Infective Agents
Current Pharmaceutical Design Torsades de Pointes in Patients with Polymyalgia Rheumatica
Current Pharmaceutical Design Hypereosinophilic Syndrome, Churg-Strauss Syndrome and Parasitic Diseases: Possible Links between Eosinophilia and Thrombosis
Current Vascular Pharmacology A New Binding Site Involving the C-terminal Domain to Design Specific Inhibitors of PepX
Protein & Peptide Letters Chromogranin A-Derived Peptides Are Involved in Innate Immunity
Current Medicinal Chemistry Pulmonary Embolism Response Team (PERT) - A New Paradigm for the Treatment of Pulmonary Embolism
Current Pharmaceutical Design Recent Tools to Overcome Antibacterial Resistance
Current Topics in Medicinal Chemistry Catheter Related Line Sepsis Resulting from Mycobacterium <i>chelonae</i> Infection in an Immunocompromised Host
Infectious Disorders - Drug Targets Secondary Stroke Prevention in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Vascular Disease Prevention (Discontinued) Hydroxychloroquine Sulfate (Plaquenil): A Possible Candidate for Pandemic SARS-CoV-2 or (COVID-19) ?
Coronaviruses Current Status of Molecular Imaging in Infections
Current Pharmaceutical Design Infection and Anemia
Infectious Disorders - Drug Targets Antibacterial Function of the Human Cathelicidin-18 Peptide (LL-37) between Theory and Practice
Protein & Peptide Letters Phytochemicals as Inhibitors of Candida Biofilm
Current Pharmaceutical Design Short Term Statin Treatment Improves Survival and Differentially Regulates Macrophage-Mediated Responses to Staphylococcus aureus
Current Pharmaceutical Biotechnology Imidazole Derivatives and their Antibacterial Activity - A Mini-Review
Mini-Reviews in Medicinal Chemistry Hallmarks in the Therapeutic Approach of Aortic Aneurysms: The Main Contributors
Current Pharmaceutical Design Novel Therapeutic Agents for Resistant Gram-Positive Infections
Current Drug Therapy New Developments in Antimicrobial Use in Sepsis
Current Pharmaceutical Design